Adial Pharmaceuticals Analyst Ratings
Adial Pharmaceuticals Analyst Ratings
While ratings are subjective and will change, the latest Adial Pharmaceuticals (ADIL) rating was a downgraded with a price target of $0.00 to $0.00. The current price Adial Pharmaceuticals (ADIL) is trading at is $0.57, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/17/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 10/13/2021 | 1993.51% | Brookline Capital | → $12 | Initiates Coverage On | → Buy |
| 06/29/2021 | 772.3% | Litchfield Hills | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/17/2022 | — | Maxim 集團 | 降級 | 買入 → 持有 | |
| 2021 年 10 月 13 日 | 1993.51% | 布魯克林資本 | → 12 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 06/29/2021 | 772.3% | 利奇菲爾德山 | → 5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Adial Pharmaceuticals Questions & Answers
Adial 製藥問題與解答
The latest price target for Adial Pharmaceuticals (NASDAQ: ADIL) was reported by Maxim Group on August 17, 2022. The analyst firm set a price target for $0.00 expecting ADIL to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
Maxim集團於2022年8月17日公佈了Adial Pharmicals（納斯達克股票代碼：ADIL）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計ADIL將在12個月內降至12個月內（可能下跌-100.00％）。去年有2家分析公司公佈了評級。
The latest analyst rating for Adial Pharmaceuticals (NASDAQ: ADIL) was provided by Maxim Group, and Adial Pharmaceuticals downgraded their hold rating.
Adial Pharmicals（納斯達克股票代碼：ADIL）的最新分析師評級由Maxim集團提供，Adial Pharmicals下調了持有評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adial Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adial Pharmaceuticals was filed on August 17, 2022 so you should expect the next rating to be made available sometime around August 17, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Adial Pharmicals的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Adial Pharmicals的最新評級是在2022年8月17日公佈的，因此您應該預計下一個評級將在2023年8月17日左右公佈。
While ratings are subjective and will change, the latest Adial Pharmaceuticals (ADIL) rating was a downgraded with a price target of $0.00 to $0.00. The current price Adial Pharmaceuticals (ADIL) is trading at is $0.57, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Adial Pharmicals（ADIL）評級已下調，目標股價爲0.00美元至0.00美元。Adial Pharmicals（ADIL）目前的交易價格爲0.57美元，超出了分析師的預期區間。
